<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="https://imcjms.com/public/assets/rss.css" ?><rss version="2.0">
<channel>
    <title>IMC Journal of Medical Science</title>
    <link>https://imcjms.com/public</link>
    <description>Ibrahim Medical College Journal of Medical Science</description>

                        <item>
                <title><![CDATA[Lipid Profile of Women with Polycystic Ovary Syndrome Attending a Tertiary Care Hospital of Dhaka City]]></title>

                                    <author><![CDATA[Rona Laila]]></author>
                                    <author><![CDATA[Nusrat Mahmud]]></author>
                                    <author><![CDATA[Monnujan Nargis]]></author>
                                    <author><![CDATA[TA Chowdhury]]></author>
                
                <link data-url="https://imcjms.com/public/registration/journal_full_text/70">
    https://imcjms.com/public/registration/journal_full_text/70
</link>
                <pubDate>Tue, 02 Aug 2016 12:07:35 +0000</pubDate>
                <category><![CDATA[Original Article]]></category>
                <comments><![CDATA[Ibrahim Med. Coll. J. 2014; 8(2): 47-49]]></comments>
                <description>Polycystic ovary syndrome (PCOS) is one of the
common disorders in women at child bearing age. The purpose of the present
study was to investigate the lipid profile in patients with polycystic ovary
syndrome.
Ibrahim Med. Coll. J. 2014; 8(2): 47-49
Address for Correspondence: Dr. Rona Laila, Assistant Professor, BIRDEM
General Hospital. 1/1 Ibrahim Sarani, Segunbagicha, Dhaka-1000, Bangladesh.
Mobile: +8801711985438, Email: ronalaila7776@gmail.com
&amp;nbsp;
One of the most common disorders in women at
child bearing age is polycystic ovary syndrome (PCOS), which is a complex
disorder affecting not only the normal development of eggs in the ovaries but
also other metabolic pathways.1-3&amp;nbsp;PCOS is a common endocrine disorder affecting
5-10% women of reproductive age.4,5&amp;nbsp;It is associated with diabetes and
cardiovascular disease.
In view of the above, the present study was
undertaken to evaluate the lipid parameters in women with PCOS.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 
Study population
Anthropometry and laboratory methods
Oral glucose tolerance test (OGTT) was performed
in all subjects following the WHO criteria (1999). The selected subjects were
requested to fast overnight (8-12 hours). In the following morning, fasting
blood samples (10 cc) was collected in an EDTA containing tube. After two hrs
of glucose load (75 gm) another 5 ml blood was drawn in another tube. Serum
lipids were determined from fasting sample.
&amp;nbsp;
The detail anthropometric characteristics of
the study population are shown in Table 1. The mean BMI±SD of the 103
participants was 25.84±5.54 kg/m2. Out of 103
study women 50 (48.5%) had family history of diabetes. Among 103 women with
PCOS, 30 (29.1%) showed impaired glucose tolerance (OGTT value: 7.8-11.0
mmol/L), 5 (4.9%) were T2DM (fasting blood sugar &amp;gt;7.0, OGTT value
&amp;gt;11.1mmol/L) and 68 (66%) showed normal glucose tolerance (OGTT value
&amp;lt;7.8 mmol/L).
Table-1: Anthropometric
and other characteristics of the study population (n=103)
&amp;nbsp;Detailed anthropometry, laboratory and other
clinical characteristics of women with PCOS having NGT, IGT and T2DM are recorded
in Table 2. Mean age of NGT, IGT, and T2DM was 23.68±4.57, 25.03±6.09 and
30.48±2.88 years respectively. The BMI of women having NGT, IGT and T2DM ranged
from 24.86 kg/m2&amp;nbsp;to 32.7
kg/m2.In NGT group
16.2% had BMI&amp;gt;30 kg/m2&amp;nbsp;where
as 23.3% of IGT and 40% of T2DM had BMI&amp;gt;30 kg/m2. The mean cholesterol levels in NGT, IGT and T2DM groups ranged
from 182 mg/dl to 236 mg/dl. Details of other lipid parameters are shown in the
Table 2.
Table-2:
Anthropometric, laboratory and other characteristics of women with PCOS having
NGT, IGT and T2DM
&amp;nbsp;Discussion
Dyslipidemia is common in PCOS compared to
weight matched controls with higher triglyceride and lower high-density
lipoprotein cholesterol.9,11&amp;nbsp;The dyslipidaemia occurs independent of BMI.14&amp;nbsp;The causes of dyslipidaemia
in PCOS are again multi-factorial. Insulin resistance appears to have an
important role mediated by simulation of lipolysis and altered expression of
lipoprotein lipase and hepatic lipase.15&amp;nbsp;It is thought that approximately 70% of the
patients with PCOS have disturbances in serum lipid levels.16&amp;nbsp;A study on Bangladeshi women
with PCOS reported increased levels of triglyceride, LDL and total cholesterol.17&amp;nbsp;In our study, the lipid
profiles of women with PCOS was generally higher than normal healthy women.
&amp;nbsp;
1.&amp;nbsp;&amp;nbsp;&amp;nbsp; Azziz R, Woods KS, Reyna R, Key TJ,
Knochenhauer ES and Yildiz BO. The prevalence and features of the polycystic
ovary syndrome in an unselected population. J Clin Endocrinol Metab
2004; 89: 2745-49.
3.&amp;nbsp;&amp;nbsp;&amp;nbsp; Taylor, A.E. Understanding the underlying
metabolic abnormalities of polycystic ovary syndrome. Am J Obstet Gynecol
1998; 179: S94-S100.
5.&amp;nbsp;&amp;nbsp;&amp;nbsp; Diamanti-Kandarakis E, Kouli CR, Bergiele
AT, et al. 
6.&amp;nbsp;&amp;nbsp;&amp;nbsp; Wild RA, Alaupovic P, Parker IJ. Lipid
and&amp;nbsp; apolipoprotein abnormalities in
hirsute women. Am J Obstet Gynecol 1992; 166: 1191-97.
8.&amp;nbsp;&amp;nbsp;&amp;nbsp; DeFronzo RA, Hendler R, Simonson. Insulin
resistance; a multifaceted syndrome responsible for NIDDM, obesity,
hypertension, dyslipidemia and atherosclerosis. Neth J Med 1997; 50:
191-97.
10.&amp;nbsp; Christian RC, Dumesic DA, Behrenbeck T, Oberg
AL, Sheedy PF et al. Prevalence and predictors of coronary artery
calcification in women with polycystic ovary syndrome. J Clin Endocrinol
Metab 2003; 88(6): 2562-68.
12.&amp;nbsp; Moran LJ, Misso M, Wild RA, Norman R. Impaired
glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary
syndrome: A systematic review and&amp;nbsp;
meta-analysis. Human Reproduction Update 2010; 16: 347-63.
14.&amp;nbsp; Wild RA, Bartholomew MJ. The influence of body
weight on lipoprotein lipids in patients with polycystic ovary syndrome. Am
J Obstet Gynecol 1988; 159: 423-27.
16.&amp;nbsp; Gateva A, Kamenov Z. Cardiovascular risk
factors in Bulgarian patients with polycystic&amp;nbsp;
ovary syndrome and/or obesity. Obstet Gynecol Int 2012; doi:
10.1155/2012/306347.
</description>

            </item>
            
    <copyright>2026 Ibrahim Medical College. All rights reserved.</copyright>
</channel>
</rss>
